A 45-year-old woman with CKD G3a from IgA nephropathy has been told about the DAPA-CKD trial. She asks what specific CKD population was studied. What

Question

A 45-year-old woman with CKD G3a from IgA nephropathy has been told about the DAPA-CKD trial. She asks what specific CKD population was studied. What were the key inclusion criteria?

Accepted Answer

DAPA-CKD enrolled adults with eGFR 25-75 mL/min/1.73m2 and uACR 200-5000 mg/g (~22-565 mg/mmol) with or without type 2 diabetes

Answer

All CKD patients regardless of GFR or proteinuria as the preferred next management strategy in this patient

Answer

Only diabetic patients were studied as the preferred next management strategy at this stage in the clinical context described

Answer

Only non-diabetic patients were included as the preferred next management strategy at this stage in the clinical context described

Answer

Only eGFR

DAPA-CKD Trial Population Inclusion — ESENeph MCQ

A 45-year-old woman with CKD G3a from IgA nephropathy has been told about the DAPA-CKD trial. She asks what specific CKD population was studied. What were the key inclusion criteria?